INO:NASDAQ
Inovio Pharmaceuticals Inc
1,01 USD
arrow_upward
+1,00%(+0,0100) 1D
20-окт., 14:59:25 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for INO...
Open
1,01 USD
High
1,06 USD
Low
0,99 USD
Mkt. cap
104,43 млн
Avg. vol.
2,85 млн
Volume
1,82 млн
52-wk high
2,72 USD
52-wk low
0,57 USD
EPS
-1,17 USD
Beta
1,61
Shares outstanding
103,40 млн
No. of employees
112
Open
1,01 USD
High
1,06 USD
Low
0,99 USD
Mkt. cap
104,43 млн
Avg. vol.
2,85 млн
Volume
1,82 млн
52-wk high
2,72 USD
52-wk low
0,57 USD
EPS
-1,17 USD
Beta
1,61
Shares outstanding
103,40 млн
No. of employees
112
News stories
From web sources and news partners
Seeking Alpha
·
31 мүнөт мурун
‘The era of stocks being the only viable investment option has ended’ – Baird Strategas’ (SP500:)
ChartMill
·
54 мүнөт мурун
Most Active S&P 500 Stocks in Today's Session
Yahoo Finance
·
1 саат мурун
Okta (OKTA): Does the AI-Identity Turnaround Make It a Stronger S&P 500 Contestant?
Profile
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development. Wikipedia
About Inovio Pharmaceuticals Inc